What does Atara Biotherapeutics, Inc. do?
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of…
What is Atara Biotherapeutics, Inc.'s P/E and P/B ratio?
Atara Biotherapeutics, Inc. has a P/E ratio of -7.3 and a P/B ratio of -2.56.
What is Atara Biotherapeutics, Inc.'s debt-to-equity ratio?
Atara Biotherapeutics, Inc. has a debt-to-equity ratio of -0.27.
How much does Atara Biotherapeutics, Inc. owe compared with what it owns?
Atara Biotherapeutics, Inc. owes $2.76 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Atara Biotherapeutics, Inc.'s Positivity rank?
Atara Biotherapeutics, Inc. is ranked #6,489 of 6,774 companies globally and #3,741 of 4,000 in United States on PositoAI, with a Positivity Score of -21,147.
Does Atara Biotherapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Atara Biotherapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 01 May 2026). It has no yellow flags.
Where can I read the latest news about Atara Biotherapeutics, Inc.?
Recent headlines about Atara Biotherapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Atara Biotherapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Atara Biotherapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.